Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases
- 1 August 2003
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (16) , 1370-1380
- https://doi.org/10.1038/sj.gt.3302007
Abstract
Protease-activatable retroviral vectors offer the possibility of targeted gene transfer into cancer cells expressing a unique set of proteases as, for example, the matrix metalloproteases (MMPs). However, it is difficult to predict which substrate sequence will be optimally cleaved by a given tumour cell type. Therefore, we developed a novel approach that allows the selection of MMP-activatable retroviruses from libraries of viruses displaying combinatorially diversified protease substrates. Starting from a virus harbouring a standard MMP-2 substrate motif, after only two consecutive cycles of diversification and in vivo selection, MMP-activatable viruses were recovered. Biochemical characterization of the selected viruses revealed that their linker peptides showed a considerably increased sensitivity for MMP-2 cleavage, and interestingly also improved the particle incorporation rate of the Env protein. Owing to the optimized linker peptide, the selected viruses exhibited a greatly enhanced spreading efficiency through human fibrosarcoma cells, while having retained the dependency on MMP activation. Moreover, cell entry efficiency and virus titres were considerably improved as compared to the parental virus displaying the standard MMP-2 substrate. The results presented imply that retroviral protease substrate libraries allow the definition of MMP substrate specificities under in vivo conditions as well as the generation of optimally adapted tumour-specific viruses.Keywords
This publication has 34 references indexed in Scilit:
- A Unique Substrate Recognition Profile for Matrix Metalloproteinase-2Journal of Biological Chemistry, 2002
- Genomic Stability of Murine Leukemia Viruses Containing Insertions at the Env-3′ Untranslated Region BoundaryJournal of Virology, 2001
- Claudin Promotes Activation of Pro-matrix Metalloproteinase-2 Mediated by Membrane-type Matrix MetalloproteinasesJournal of Biological Chemistry, 2001
- Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax ToxinJournal of Biological Chemistry, 2001
- Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectorsGene Therapy, 1999
- Targeting Retroviral Vectors to CD34-Expressing Cells: Binding to CD34 Does Not Catalyze Virus-Cell FusionHuman Gene Therapy, 1999
- In vivo selection of protease cleavage sites from retrovirus display librariesNature Biotechnology, 1998
- Targeting Retroviral Vectors to Vascular Lesions by Genetic Engineering of the MoMLV gp70 Envelope ProteinHuman Gene Therapy, 1997
- A Gene Delivery System Activatable by Disease-Associated Matrix MetalloproteinasesHuman Gene Therapy, 1997
- Antibody engineering by parsimonious mutagenesisGene, 1993